Viewing Study NCT02488967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-02-26 @ 4:17 PM
Study NCT ID: NCT02488967
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-03
First Post: 2015-06-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Sponsor: NRG Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Adenocarcinoma View
None Estrogen Receptor Negative View
None HER2/Neu Negative View
None Progesterone Receptor Negative View
None Stage IB Breast Cancer View
None Stage IIA Breast Cancer View
None Stage IIB Breast Cancer View
None Stage IIIA Breast Cancer View
None Stage IIIC Breast Cancer View
None Triple-Negative Breast Carcinoma View
Keywords: